A61K 31/095
Sulfur, selenium, or tellurium compounds
Official title: Sulfur, selenium, or tellurium compounds, e.g. thiols
A61K31/095 (Sulfur, selenium, or tellurium compounds) appears on 938 US grants and 1,442 published applications in this corpus.
Search patents in A61K- Granted patents
- 938
- Published applications
- 1,442
- Assignees
- 776
- Inventors
- 2,648
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 5 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 5 | 0 |
| 1982 | 4 | 0 |
| 1983 | 1 | 0 |
| 1984 | 5 | 0 |
| 1985 | 2 | 0 |
| 1986 | 10 | 0 |
| 1987 | 8 | 0 |
| 1988 | 7 | 0 |
| 1989 | 13 | 0 |
| 1990 | 16 | 0 |
| 1991 | 14 | 0 |
| 1992 | 12 | 0 |
| 1993 | 10 | 0 |
| 1994 | 5 | 0 |
| 1995 | 8 | 0 |
| 1996 | 9 | 0 |
| 1997 | 16 | 0 |
| 1998 | 12 | 0 |
| 1999 | 21 | 0 |
| 2000 | 21 | 0 |
| 2001 | 22 | 5 |
| 2002 | 13 | 18 |
| 2003 | 11 | 36 |
| 2004 | 9 | 49 |
| 2005 | 17 | 37 |
| 2006 | 13 | 27 |
| 2007 | 9 | 44 |
| 2008 | 6 | 52 |
| 2009 | 12 | 40 |
| 2010 | 17 | 76 |
| 2011 | 9 | 58 |
| 2012 | 22 | 50 |
| 2013 | 40 | 62 |
| 2014 | 32 | 65 |
| 2015 | 44 | 83 |
| 2016 | 54 | 71 |
| 2017 | 48 | 93 |
| 2018 | 54 | 65 |
| 2019 | 56 | 86 |
| 2020 | 50 | 80 |
| 2021 | 40 | 69 |
| 2022 | 40 | 65 |
| 2023 | 34 | 65 |
| 2024 | 32 | 64 |
| 2025 | 28 | 50 |
| 2026 | 17 | 32 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- PH-responsive lipidoid nanoparticles for intracellular mRNA delivery25 Aug 2026US 12,714,690 B2Trustees of Tufts College
- Compounds for inhibition of inflammation25 Aug 2026US 12,714,716 B2Children's Medical Center Corporation
- Compositions for disrupting biofilm formation and for treating biofilm-related disorders18 Aug 2026US 12,708,612 B2AHV International B.V.
- Botanicals as WNT/beta-catenin activators, molecular pathway regulators, tissue regenerators and health biomarker regulators18 Aug 2026US 12,708,655 B2Arbor Life Holdings, Ltd.
- Tethering cysteine residues using cyclic disulfides18 Aug 2026US 12,709,745 B2Brandeis University
- Protecting a bioactive and/or precursor thereof24 Sep 2026US 2026/0283969 A1Commonwealth Scientific and Industrial Research Organisation
- Glycopyrrolate salts24 Sep 2026US 2026/0284007 A1Journey Medical Corporation
- Methods for developing companion supplements for dogs, related compositions, and systems17 Sep 2026US 2026/0272876 A1Life's Abundance
- Selenoglycoside decoys of glycosylation for anti-inflammatory and antiviral pharmaceuticals17 Sep 2026US 2026/0272965 A1
- Inhibitors of ca 2+/calmodulin-dependent protein kinase ii (camkii) that do not inhibit long-term potentiation (ltp) induction and therapeutic uses thereof10 Sep 2026US 2026/0263429 A1The Regents of the University of Colorado, a body corporate
Most cited
By later US patents
- Localized use of nitric oxide-adducts to prevent internal tissue damage146US 6,087,479 ANitroMed, Inc. · 2000
- Compositions comprising hyaluronic acid and drugs122US 5,985,850 AHyal Pharmaceuticals Corporation · 1999
- Anti-estrogenic compounds and compositions119US 5,395,842 AEndorecherche, Inc. · 1995
- Anaerobic bacterial preparations of intestinal origin and their use90US 4,657,762 AFarmos-Yhtyma Oy · 1987
- Topical treatment and composition90US 4,661,524 ABeecham Group Limited · 1987